The latest report by IMARC Group, titled "Separation Systems for Commercial Biotechnology Market Report by Methods (Modern Methods, Conventional Methods), Application (Pharmaceutical, Food and Cosmetics, Agriculture, and Others), and Region 2025-2033," finds that the global separation systems for commercial biotechnology market size reached USD 28.2 Billion in 2024. Separation systems for commercial biotechnology are solutions used to purify and separate biological products from complex mixtures and solutions such as diagnostic reagents, biochemicals, and biopharmaceuticals. It includes various equipment and devices, such as membranes, filters, centrifuges, chromatographs, biochips, and microarrays. These solutions also offer various benefits, such as higher recovery and minimal waste generation. Owing to these properties, separation systems find extensive applications across pharmaceutical, food and beverage (F&B), cosmetic, and agriculture industries.
Global Separation Systems for Commercial Biotechnology Market Trends:
The market is primarily driven by the expanding pharmaceutical industry. In addition, the escalating demand for personalized drugs, biopharmaceuticals, and cell-based therapies due to the increasing prevalence of chronic medical ailments represents another major growth-inducing factor. Besides this, various technological advancements, including the development of innovative upstream bioprocessing technologies that eliminate biohazardous by-products using simplified procedures, are contributing to the market growth. Moreover, the improving healthcare infrastructure, especially in developing countries, and extensive research and development (R&D) in the field of biotechnology are also creating a positive market outlook across the globe. Looking forward, IMARC Group expects the market value to reach USD 44.7 Billion by 2033, exhibiting a CAGR of 4.98% during the forecast period (2025-2033).
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Methods, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Agilent Technologies Inc., Becton Dickinson and Company, Bio-Rad Laboratories Inc., Hitachi Ltd., Merck KGaA, Pall Corporation (Danaher Corporation), PerkinElmer Inc., Qiagen N.V, Repligen Corporation, Sartorius AG, Shimadzu Corporation and Thermo Fisher Scientific. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N A
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800